OCSAW
NASDAQ
$4.07
Oculis Holding AG - Warrants (02/03/2028) (OCSAW)
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company is headquartered in Zug, Switzerland.
This company is also listed under the following ticker: OCS.
Beta (5Y)
1.01
Price Chart
Growth & Risk
Beta (5Y)1.01
Sharpe Ratio-0.03